1. Home
  2. BIOX vs ATOS Comparison

BIOX vs ATOS Comparison

Compare BIOX & ATOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bioceres Crop Solutions Corp.

BIOX

Bioceres Crop Solutions Corp.

HOLD

Current Price

$1.64

Market Cap

109.2M

Sector

Industrials

ML Signal

HOLD

Logo Atossa Therapeutics Inc.

ATOS

Atossa Therapeutics Inc.

HOLD

Current Price

$0.72

Market Cap

100.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIOX
ATOS
Founded
2001
2009
Country
Argentina
United States
Employees
N/A
N/A
Industry
Agricultural Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
109.2M
100.8M
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
BIOX
ATOS
Price
$1.64
$0.72
Analyst Decision
Buy
Strong Buy
Analyst Count
3
3
Target Price
$4.42
$6.33
AVG Volume (30 Days)
370.1K
911.6K
Earning Date
11-12-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$318,158,904.00
N/A
Revenue This Year
$1.25
N/A
Revenue Next Year
$27.91
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.20
$0.55
52 Week High
$7.44
$1.29

Technical Indicators

Market Signals
Indicator
BIOX
ATOS
Relative Strength Index (RSI) 49.40 40.51
Support Level $1.40 $0.68
Resistance Level $1.65 $0.99
Average True Range (ATR) 0.11 0.05
MACD 0.01 0.01
Stochastic Oscillator 48.17 11.57

Price Performance

Historical Comparison
BIOX
ATOS

About BIOX Bioceres Crop Solutions Corp.

Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.

About ATOS Atossa Therapeutics Inc.

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

Share on Social Networks: